세계의 유전자 검사 시장 규모, 점유율, 성장 분석 : 기술별, 용도별, 제품별, 채널별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Genetic Testing Market Size, Share, and Growth Analysis, By Technology (Next Generation Sequencing, Array Technology), By Application (Ancestry & Ethnicity, Traits Screening), By Product, By Channel, By End Use, By Region - Industry Forecast 2025-2032
상품코드:1681610
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
유전자 검사 세계 시장 규모는 2023년 80억 달러로 평가되었습니다. 또한, 2024년 98억 4,000만 달러에서 2032년에는 515억 5,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 23.0%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
유전자 검사 시장은 기술 발전, 헬스케어 수요 증가, 일반 대중의 인식 향상으로 인해 크게 성장하고 있습니다. 이러한 급격한 성장의 주요 원인은 다양한 건강 상태에 대한 인식 개선과 교육 이니셔티브, 미디어의 광범위한 보도가 뒷받침하고 있습니다. 기술 혁신, 특히 차세대 염기서열 분석(NGS)은 유전자 검사의 속도, 정확성, 경제성을 획기적으로 향상시켰습니다. 그러나 유전자 정보의 악용, 보험 및 고용 분야에서의 차별 가능성 등 윤리적 문제와 프라이버시 문제에 직면해 있습니다. 이러한 장애물에도 불구하고, 유전자 검사의 적용 범위 확대와 유전체학의 지속적인 발전은 시장에 큰 성장 기회를 가져다주며, 개인 맞춤형 의료 및 헬스케어 솔루션의 유망한 미래를 제시하고 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
유전자 검사 시장 규모 : 기술별&CAGR(2025-2032년)
시장 개요
차세대 시퀀싱
어레이 기술
PCR 기반 검사
FISH 검사
기타
유전자 검사 시장 규모 : 용도별&CAGR(2025-2032년)
시장 개요
조상 및 민족
특성 검사
유전 질환 보유 여부
신생아 검사
건강 및 웰니스 - 소인/위험/경향
유전자 검사 시장 규모 : 제품별&CAGR(2025-2032년)
시장 개요
소모품
장비
소프트웨어 및 서비스
유전자 검사 시장 규모 : 채널별&CAGR(2025-2032년)
시장 개요
온라인
오프라인
유전자 검사 시장 규모 : 최종 용도별&CAGR(2025-2032년)
시장 개요
병원 및 클리닉
진단 실험실
기타
유전자 검사 시장 규모 : 지역별&CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
Illumina, Inc.(USA)
Roche Holding AG(Switzerland)
Thermo Fisher Scientific Inc.(USA)
QIAGEN N.V.(Netherlands)
Abbott Laboratories(USA)
Agilent Technologies, Inc.(USA)
Bio-Rad Laboratories, Inc.(USA)
Danaher Corporation(USA)
Myriad Genetics, Inc.(USA)
23andMe, Inc.(USA)
Invitae Corporation(USA)
Natera, Inc.(USA)
NeoGenomics, Inc.(USA)
Guardant Health, Inc.(USA)
Siemens Healthineers AG(Germany)
Hologic, Inc.(USA)
BGI Genomics Co., Ltd.(China)
Eurofins Scientific(Luxembourg)
Adaptive Biotechnologies Corporation(USA)
결론과 제안
LSH
영문 목차
영문목차
Global Genetic Testing Market size was valued at USD 8.0 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 51.55 billion by 2032, growing at a CAGR of 23.0% during the forecast period (2025-2032).
The genetic testing market has experienced significant growth due to advancements in technology, increasing healthcare demands, and heightened public awareness. This surge is primarily driven by enhanced awareness and educational initiatives about various prevalent health conditions, supported by extensive media coverage. Technological innovations, particularly in Next-Generation Sequencing (NGS), have drastically improved the speed, accuracy, and affordability of genetic tests. However, the market faces challenges regarding ethical concerns and privacy issues, including the potential misuse of genetic information and discrimination from insurance or employment sectors. Despite these hurdles, the expanding applications of genetic testing and ongoing advancements in genomics present substantial growth opportunities for the market, signaling a promising future in personalized medicine and healthcare solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Genetic Testing Market Segments Analysis
Global Genetic Testing Market is segmented by Technology, Application, Product, Channel, End Use and region. Based on Technology, the market is segmented into Next Generation Sequencing, Array Technology, PCR - based Testing, FISH and Others. Based on Application, the market is segmented into Ancestry & Ethnicity, Traits Screening, Genetic Disease Carrier Status, New Baby Screening and Health and Wellness - Predisposition/ Risk / Tendency. Based on Product, the market is segmented into Consumables, Equipment and Software & Services. Based on Channel, the market is segmented into Online and Offline. Based on End Use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Genetic Testing Market
The global genetic testing market is significantly propelled by the increasing awareness and demand for personalized medicine. As individuals become more informed about the benefits of tailored healthcare solutions, there is a substantial shift towards genetic testing, which provides valuable insights into a person's unique genetic makeup. This heightened awareness fosters a growing preference for personalized treatment plans that can enhance efficacy and minimize adverse effects. Additionally, advancements in technology and the consequential reduction in testing costs have further fueled consumer interest. Consequently, the focus on personalized approaches in medicine continuously drives the expansion of the genetic testing sector worldwide.
Restraints in the Global Genetic Testing Market
One of the significant challenges facing the global genetic testing market is the issue of limited insurance coverage. Many insurance providers are hesitant to fully cover genetic testing expenses, often due to high costs and perceived uncertainties regarding the benefits of various tests. This lack of comprehensive coverage can deter individuals from seeking necessary genetic assessments, as out-of-pocket expenses may be prohibitive for many patients. Consequently, this restriction hampers market growth by limiting access to testing services, which in turn affects patient outcomes and the overall demand for advancements in genetic testing technologies and services.
Market Trends of the Global Genetic Testing Market
The Global Genetic Testing market is witnessing a significant trend of expanding beyond traditional DNA analysis to incorporate advanced methodologies, including RNA profiling and epigenetic testing. This evolution is pivotal as it enhances the detection of genetic variations and provides profound insights into how these alterations influence gene expression and overall health. By considering factors that do not alter the DNA sequence yet affect cellular functionality, genetic testing is becoming more comprehensive and personalized. This trend is expected to drive demand for innovative testing solutions, ultimately leading to more precise healthcare interventions and tailored treatments, thereby propelling market growth in the coming years.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Genetic Testing Market Size by Technology & CAGR (2025-2032)
Market Overview
Next Generation Sequencing
Array Technology
PCR - based Testing
FISH
Others
Global Genetic Testing Market Size by Application & CAGR (2025-2032)
Market Overview
Ancestry & Ethnicity
Traits Screening
Genetic Disease Carrier Status
New Baby Screening
Health and Wellness - Predisposition/ Risk / Tendency
Global Genetic Testing Market Size by Product & CAGR (2025-2032)
Market Overview
Consumables
Equipment
Software & Services
Global Genetic Testing Market Size by Channel & CAGR (2025-2032)
Market Overview
Online
Offline
Global Genetic Testing Market Size by End Use & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Diagnostic Laboratories
Others
Global Genetic Testing Market Size & CAGR (2025-2032)
North America (Technology, Application, Product, Channel, End Use)
US
Canada
Europe (Technology, Application, Product, Channel, End Use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Technology, Application, Product, Channel, End Use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Technology, Application, Product, Channel, End Use)
Brazil
Rest of Latin America
Middle East & Africa (Technology, Application, Product, Channel, End Use)